geckler
Long

IBB Long hanky sell off IMO

NASDAQ:IBB   ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND
92 0 0
IBB             closed below lower BBs for only the 5th time in the last couple years Friday on some pretty "janky" headlines if you ask me about Henry A. Waxman (D-Beverly Hills) wants Gilead Sciences Inc             . to explain why it priced its new hepatitis C drug, Sovaldi, at $1,000 a pill. Considering nobody asked any questions about the targeted oncology drugs are even more and give people a whole 6-18 weeks efficacy over placebo in a rather miserable existance - seems odd to me the mouse man cares about a relatively effective Hep C drug that more or less cures people. Sometimes sectors that have experienced huge runs by any means necessary sell off but this is some mark ass stuff. Long.
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out